Institutional investors hold a majority ownership of ABBV through the 67.49% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2016, these large investors purchased a net $3.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LPL FINANCIAL LLC Bought 454.1 Thousand shares of AbbVie